Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Vaccine
|
October 15, 2019
Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)
Daniel Cowley, Rini Mulia Sari, Amanda Handley, et al.
Plos Medicine
|
February 12, 2026
Evaluation of rotavirus, pneumococcal conjugate and human papillomavirus vaccination in four Pacific island countries: A cost-effectiveness modelling study
Natalie Carvalho, Emma Watts, Victoria L Oliver, et al.
Plos One
|
April 13, 2018
Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: A cross-sectional study
Eileen M Dunne, Chrysanti Murad, Sunaryati Sudigdoadi, et al.
ACS Synthetic Biology
|
August 8, 2022
Standardization of Synthetic Biology Tools and Assembly Methods for <i>Saccharomyces cerevisiae</i> and Emerging Yeast Species
Koray Malcı, Emma Watts, Tania Michelle Roberts, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 28, 2019
Pneumococcal carriage, density, and co-colonization dynamics: A longitudinal study in Indonesian infants
Chrysanti Murad, Eileen M Dunne, Sunaryati Sudigdoadi, et al.
BMJ Open
|
December 1, 2022
Prevention of young infant infections using oral azithromycin in labour in Fiji (Bulabula MaPei): study protocol of a randomised control trial
Maeve Hume-Nixon, Tupou Ratu, Stephanie Clark, et al.
The Lancet. Infectious Diseases
|
August 31, 2015
Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial
Julie E Bines, Margaret Danchin, Pamela Jackson, et al.
The Journal of Infection
|
March 16, 2026
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia
Nadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
The Journal of Infection
|
February 20, 2025
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose
Nadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
The New England Journal of Medicine
|
February 22, 2018
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth
Julie E Bines, Jarir At Thobari, Cahya Dewi Satria, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Vaccine
|
October 15, 2019
Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)
Daniel Cowley, Rini Mulia Sari, Amanda Handley, et al.
Plos Medicine
|
February 12, 2026
Evaluation of rotavirus, pneumococcal conjugate and human papillomavirus vaccination in four Pacific island countries: A cost-effectiveness modelling study
Natalie Carvalho, Emma Watts, Victoria L Oliver, et al.
Plos One
|
April 13, 2018
Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: A cross-sectional study
Eileen M Dunne, Chrysanti Murad, Sunaryati Sudigdoadi, et al.
ACS Synthetic Biology
|
August 8, 2022
Standardization of Synthetic Biology Tools and Assembly Methods for <i>Saccharomyces cerevisiae</i> and Emerging Yeast Species
Koray Malcı, Emma Watts, Tania Michelle Roberts, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 28, 2019
Pneumococcal carriage, density, and co-colonization dynamics: A longitudinal study in Indonesian infants
Chrysanti Murad, Eileen M Dunne, Sunaryati Sudigdoadi, et al.
BMJ Open
|
December 1, 2022
Prevention of young infant infections using oral azithromycin in labour in Fiji (Bulabula MaPei): study protocol of a randomised control trial
Maeve Hume-Nixon, Tupou Ratu, Stephanie Clark, et al.
The Lancet. Infectious Diseases
|
August 31, 2015
Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial
Julie E Bines, Margaret Danchin, Pamela Jackson, et al.
The Journal of Infection
|
March 16, 2026
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia
Nadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
The Journal of Infection
|
February 20, 2025
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose
Nadia Mazarakis, Zheng Quan Toh, Eleanor Neal, et al.
The New England Journal of Medicine
|
February 22, 2018
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth
Julie E Bines, Jarir At Thobari, Cahya Dewi Satria, et al.
Page
of 5